12β,14-Dihy-droxy-3-oxo-5β,20(22)-cardenolide monohydrate
- PMID: 21588919
- PMCID: PMC3009025
- DOI: 10.1107/S1600536810038031
12β,14-Dihy-droxy-3-oxo-5β,20(22)-cardenolide monohydrate
Abstract
The title compound, digoxigenone, C(23)H(30)O(5)·H(2)O, was biotransformed from digoxigenin. In the crystal, inter-molecular O-H⋯O hydrogen bonds contribute to the formation of a three-dimensional supra-molecular structure. The title compound has three fused six-membered rings (A,B,C) and two non-fused five-membered rings (D,E). As in other structures, compound nucleus has a cis-trans-cis conformation for the A-B,B-C,C-D ring junctions with rings A, B and C exhibiting chair conformations.
Figures
References
-
- Kreis, W., Hensel, A. & Stuhlemmer, U. (1998). Planta Med.64, 491–499.
-
- Pádua, R. M., Oliveira, A. B., Souza Filho, J. D., Takahashi, J. A., Silva, M. A. & Braga, F. C. (2007). J. Braz. Chem. Soc.18, 1303–1310.
-
- Pádua, R. M., Oliveira, A. B., Souza Filho, J. D., Vieira, G. J., Takahashi, J. A. & Braga, F. C. (2005). J. Braz. Chem. Soc.16, 614–619.
-
- Rigaku (2005). CrystalClear Rigaku Corporation, Tokyo, Japan.
-
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials